The government is harnessing science and technology to significantly enhance the disease resistance of a widely cultivated ...

Northeastern University researchers used an original machine learning tool to predict how genetic mutations cause a rare metabolic disease known as OTC deficiency, uncovering some underlying ...

Since their initial rollout in 1994, genetically modified organisms (GMOs, aka biotechnology) have erupted in a firestorm of controversy. Derided as grotesque “Frankenfoods,” opponents have claimed ...

Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...

When it came time to start a family, Sarah Elizabeth Orlando, 33, knew she would go about it differently. Before she was born, an in-utero amniocentesis had confirmed she carried the gene for fragile ...

Agrobacterium tumefaciens magnified 15,000 times in an image captured earlier this year with a scanning electron microscope at Iowa State University's Roy J. Carver High Resolution Microscopy Facility ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Scientists have a new clue in the long quest to decipher what makes us uniquely human: tiny changes in brain chemistry that set us apart from our closest hominin cousins. In a study published Monday ...

Cock Van Oosterhout receives funding from the Royal Society for conservation genomics work on threatened bird species in Mauritius, and a donation by the Colossal Foundation for conservation genomic ...

These mutations improve biocontainment, transformation stability, and overall performance in genetic engineering of plants. Complementing the strains, researchers also developed new plasmids and a ...

July 11 (Reuters) - The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's (RARE.O), opens new tab experimental gene therapy to treat a rare inherited disorder, ...